Analisis Deskriptif dengan Kombinasi AI Hubungan Kadar Kreatinin dengan Jenis Kelamin pada Pasien Gagal Ginjal Kronik (GGK) di RS. Boedjasin Tahun 2026

Authors

  • Putri Nur Riani Politeknik Kesehatan Borneo Citra Medika, Pelaihari, Indonesia
  • Ratih Indah Sari Politeknik Kesehatan Borneo Citra Medika, Pelaihari, Indonesia
  • Yuvita Yuvita Politeknik Kesehatan Borneo Citra Medika, Pelaihari, Indonesia
  • Yolanda Yolanda Politeknik Kesehatan Borneo Citra Medika, Pelaihari, Indonesia
  • Ijul Ijul Politeknik Kesehatan Borneo Citra Medika, Pelaihari, Indonesia

DOI:

https://doi.org/10.53863/kst.v8i02.2463

Keywords:

chronic kidney disease, serum creatinine, sex, renal function, cross-sectional study

Abstract

Chronic kidney disease (CKD) is a progressive disorder characterized by a gradual decline in kidney function, resulting in the accumulation of metabolic waste products, including serum creatinine. Serum creatinine is one of the most commonly used laboratory parameters for assessing renal function. Physiologically, sex influences serum creatinine levels because of differences in muscle mass; however, findings regarding this association among patients with CKD remain inconsistent. This study aimed to analyze the association between serum creatinine levels and sex among patients with chronic kidney disease at Hadji Boejasin Regional General Hospital. This study employed a descriptive analytic design with a cross-sectional approach. A total of 59 patients diagnosed with chronic kidney disease were included using the total sampling technique based on medical record data. Descriptive statistics were used to summarize participant characteristics. The association between variables was analyzed using the Mann–Whitney U test because the serum creatinine data were not normally distributed according to the Shapiro–Wilk test. Of the 59 participants, 31 (52.5%) were female and 28 (47.5%) were male. The overall mean serum creatinine level was 9.25 ± 6.30 mg/dL. Female patients had a slightly higher mean serum creatinine level (9.55 mg/dL) than male patients (8.91 mg/dL). However, the difference was not statistically significant (p = 0.434). There was no statistically significant association between sex and serum creatinine levels among patients with chronic kidney disease at Hadji Boejasin Regional General Hospital. The findings suggest that serum creatinine levels in CKD patients are more strongly influenced by the degree of renal function impairment than by biological differences between males and females

References

Awdishu, L., Maxson, R., Gratt, C., Rubenzik, T., & Battistella, M. (2025). KDIGO 2024 clinical practice guideline on evaluation and management of chronic kidney disease: A primer on what pharmacists need to know. American Journal of Health-System Pharmacy, 82(12), 660–671. https://doi.org/10.1093/ajhp/zxaf044

Delanaye, P., Björk, J., Christensson, A., et al. (2021). A step forward for estimating GFR in clinical practice. Kidney International, 100(4), 729–731. https://doi.org/10.1016/j.kint.2021.06.032

Hill, N. R., Fatoba, S. T., Oke, J. L., et al. (2020). Global prevalence of chronic kidney disease: A systematic review and meta-analysis. PLoS ONE, 15(7), e0237091. https://doi.org/10.1371/journal.pone.0237091

Inker, L. A., Eneanya, N. D., Coresh, J., et al. (2021). New creatinine- and cystatin C-based equations to estimate GFR without race. New England Journal of Medicine, 385(19), 1737–1749. https://doi.org/10.1056/NEJMoa2102953

Kalantar-Zadeh, K., Jafar, T. H., Nitsch, D., Neuen, B. L., & Perkovic, V. (2021). Chronic kidney disease. The Lancet, 398(10302), 786–802. https://doi.org/10.1016/S0140-6736(21)00519-5

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, 105(4 Suppl.), S117–S314.

Levey, A. S., Titan, S. M., Powe, N. R., Coresh, J., & Inker, L. A. (2020). Kidney disease, race, and GFR estimation. Clinical Journal of the American Society of Nephrology, 15(8), 1203–1212. https://doi.org/10.2215/CJN.12791019

National Kidney Foundation. (2021). KDOQI Clinical Practice Guideline for Nutrition in Chronic Kidney Disease: 2020 Update. American Journal of Kidney Diseases, 76(3 Suppl. 1), S1–S107.

Pottel, H., Björk, J., Rule, A. D., et al. (2023). Cystatin C-based equation to estimate glomerular filtration rate without race and sex. New England Journal of Medicine, 388(4), 333–343. https://doi.org/10.1056/NEJMoa2203769

Stevens, P. E., & Levin, A. (2021). Evaluation and management of chronic kidney disease: Synopsis of the KDIGO guideline. Annals of Internal Medicine, 174(9), 1314–1321.

United States Renal Data System. (2024). USRDS 2024 Annual Data Report: Epidemiology of Kidney Disease in the United States. National Institutes of Health.

World Health Organization. (2023). Noncommunicable diseases: Key facts. Geneva: World Health Organization.

Cai, X., et al. (2025). Association between creatinine biomarkers and chronic kidney disease: A population-based study. Frontiers in Medicine

Published

2026-08-18

How to Cite

Riani, P. N., Sari, R. I., Yuvita, Y., Yolanda, Y., & Ijul, I. (2026). Analisis Deskriptif dengan Kombinasi AI Hubungan Kadar Kreatinin dengan Jenis Kelamin pada Pasien Gagal Ginjal Kronik (GGK) di RS. Boedjasin Tahun 2026. Jurnal Kridatama Sains Dan Teknologi, 8(02), 613–622. https://doi.org/10.53863/kst.v8i02.2463

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.